Emerging Data Raise Questions About Antigen Tests and Nasal Swabs
The New York Times
A new study adds to evidence that common rapid tests may fail to detect some Omicron cases in the first days of infection.
A small, new real-world study suggests that two widely used at-home antigen tests, the Abbott BinaxNOW and Quidel QuickVue, may fail to detect some Omicron infections even when people are carrying high levels of the coronavirus.
The study, which has not yet been peer-reviewed, focused on 30 people infected with the virus at five workplaces that experienced what were most likely outbreaks of the Omicron variant in December. The people received both saliva-based P.C.R. tests and rapid antigen tests using nasal swabs.
It took three days, on average, for people to test positive on a rapid antigen test after their first positive P.C.R. result. In four cases, people transmitted the virus to others while the rapid test showed the negative result, according to the study, which was conducted by several members of the Covid-19 Sports and Society Working Group.
Once confined to the five boroughs, the classic street snack has now gone fully nationwide.
But the report, on the experiences of 13 patients, found that the drug had no benefit for some people and that some who benefited said the improvement didn’t last.
Some older Americans have come to depend on virtual consultations with doctors, covered by Medicare. To keep that option in the future, Congress will have to act quickly.
Scientists say the snail darter, whose endangered species status delayed the building of a dam in Tennessee in the 1970s, is a genetic match of a different fish.
Modern religious leaders are experimenting with A.I. just as earlier generations examined radio, television and the internet.
More than 130 years after its inventor tried to introduce it in the U.S., whiskey made with a mold called koji is catching on in bars and stores.
Dr. Vivek Murthy’s report cites studies linking alcoholic beverages to at least seven malignancies, including breast cancer. But to add warning labels, Congress would have to act.
Not in this universe, a new study concludes.